Endovascular treatment of calcific lesions of the common femoral artery using atherectomy device associated with scoring balloon angioplasty in diabetic patients with high "major amputation" risk.


Journal

Vascular
ISSN: 1708-539X
Titre abrégé: Vascular
Pays: England
ID NLM: 101196722

Informations de publication

Date de publication:
Jun 2022
Historique:
pubmed: 1 6 2021
medline: 18 5 2022
entrez: 31 5 2021
Statut: ppublish

Résumé

To investigate the outcomes of patients with calcific lesions in the common femoral artery undergoing endovascular procedures with atherectomy device and scoring balloon angioplasty combined with treatment of steno-occlusive disease of the remaining arterial districts of the lower limb. Between January 2015 and December 2018, 11 diabetic patients at high risk for "major amputation", with calcific lesions of the common femoral artery and ischemic ulcers requiring endovascular treatment were retrospectively evaluated. Technical success was defined as revascularization of the common femoral artery with a residual stenosis lower than 30%. Primary endpoints were an immediate increase of perilesional transcutaneous oxygen pressure (TCPO The success rate of the revascularization procedures was 100%. No patient underwent surgical conversion. One case of peri-operative bleeding at the brachial access site was observed. There were no cases of arterial dissection or undesired distal embolization. The average baseline value of perilesional TCPO Endovascular approach for severely calcified atherosclerotic lesions of the common femoral artery seems to represent a valid therapeutic option associated with promising results in terms of clinical outcome and low complication rates.

Identifiants

pubmed: 34056973
doi: 10.1177/17085381211019244
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

463-473

Auteurs

Daniele Morosetti (D)

UOSD Radiologia Interventistica, University Hospital Policlinico Tor Vergata, Roma, Italy.

Marcello Chiocchi (M)

UOC Diagnostica per Immagini, University Hospital Policlinico Tor Vergata, Roma, Italy.

Renato Argirò (R)

UOSD Radiologia Interventistica, University Hospital Policlinico Tor Vergata, Roma, Italy.

Fabio Salimei (F)

UOSD Radiologia Interventistica, University Hospital Policlinico Tor Vergata, Roma, Italy.

Marco Nezzo (M)

UOSD Radiologia Interventistica, University Hospital Policlinico Tor Vergata, Roma, Italy.

Sofia Vidali (S)

UOSD Radiologia Interventistica, University Hospital Policlinico Tor Vergata, Roma, Italy.

Fulvio Gasparrini (F)

UOSD Radiologia Interventistica, University Hospital Policlinico Tor Vergata, Roma, Italy.

Marco Meloni (M)

Diabetic foot Unit, University Hospital Policlinico Tor Vergata, Roma, Italy.

Luigi Uccioli (L)

Diabetic foot Unit, University Hospital Policlinico Tor Vergata, Roma, Italy.

Roberto Gandini (R)

UOSD Radiologia Interventistica, University Hospital Policlinico Tor Vergata, Roma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH